Stress, Depression, and Neuroplasticity: A Convergence of Mechanisms
The DOI matches its Crossref record; 257 of the 257 references it cites were found in a registry or an index.
Abstract
Increasing evidence demonstrates that neuroplasticity, a fundamental mechanism of neuronal adaptation, is disrupted in mood disorders and in animal models of stress. Here we provide an overview of the evidence that chronic stress, which can precipitate or exacerbate depression, disrupts neuroplasticity, while antidepressant treatment produces opposing effects and can enhance neuroplasticity. We discuss neuroplasticity at different levels: structural plasticity (such as plastic changes in spine and dendrite morphology as well as adult neurogenesis), functional synaptic plasticity, and the molecular and cellular mechanisms accompanying such changes. Together, these studies elucidate mechanisms that may contribute to the pathophysiology of depression. Greater appreciation of the convergence of mechanisms between stress, depression, and neuroplasticity is likely to lead to the identification of novel targets for more efficacious treatments.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“current evidence indicates that impairment in growth factor signaling is associated with depressed mood (Pittenger and Duman 2008).”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Pittenger and Duman 2008
In the citing paper
“neurotrophic growth factors and related signaling pathways constitute major players in neuroplasticity”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Pittenger and Duman 2008
In the citing paper
“In addition, clean-cut evidence shows that antidepressants require neuroplasticity pathways to rescue the observed deficits in neuronal and synaptic plasticity often associated with mood disorders (Pittenger and Duman 2008).”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Pittenger and Duman 2008
In the citing paper
“While traditional antidepressants acutely increase synaptic levels of monoamines, their chronic administration leads to changes in structural neuroplasticity that are contemporaneous with their clinical therapeutic effects (10–12).”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [10]
In the citing paper
“these changes in neural circuitry are believed to underlie the deficits in learning/memory, mood, motivation, and reward seeking that are characteristic of depression and related disorders (10, 67–74)”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [10]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., et al. (2003) · Science · doi:10.1126/science.1083968 · Cited by 8,120 · cited 1×
“The relationship between psychosocial stressors and the development of depression in susceptible individuals has long been apparent (Kendler et al, 1999; Caspi et al, 2003).”
BackgroundNeurogenesis in the adult human hippocampus
Eriksson, P. S., Perfilieva, E., Björk-Eriksson, T., Alborn, A.-M., Nordborg, C., Peterson, D. A., & Gage, F. H. (1998) · Nature Medicine · doi:10.1038/3305 · Cited by 6,369
The Organization of Behavior; A Neuropsychological Theory.
Attneave, F., B., M., & Hebb, D. O. (1950) · The American Journal of Psychology · doi:10.2307/1418888 · Cited by 5,146
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321 · cited 1×
“As neurogenesis appears to be required for the behavioral response to antidepressants in rodents (Santarelli et al, 2003; see below) and impaired neurogenesis has been hypothesized to represent a core pathophysiological feature of major depression (Duman, 2004), this effect represents yet another…”
BackgroundSelf-citationThe Organization of Behavior: A Neuropsychological Theory
(1950) · Journal of the American Medical Association · doi:10.1001/jama.1950.02910470083028 · Cited by 4,195
Malenka, R. C., & Bear, M. F. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.012 · Cited by 3,968
The molecular biology of memory storage: a dialogue between genes and synapses
Kandel, E. R. (2001) · Science · doi:10.1126/science.1067020 · Cited by 3,917 · cited 2×
“CREB, and other inducible transcription factors, induce effector genes that contribute to the stabilization of synaptic plasticity (Kandel, 2001).”
BackgroundEgan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00035-7 · Cited by 3,888
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
Research works printed but not linked: 3
- American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders (DSM) IV-TR. American Psychiatric Press: Washington, DC.
- Nemeroff CB (2006). Use of atypical antipsychotics in refractory depression and anxiety. J Clin Psych 66 (S8): 13–21.
- O'Connor JJ, Rowan MJ, Anwyl R (1993). Naunyn Schmiedebergs Arch. Pharmacology 348: 158–163.
Cited by
Items 401–500 of 1,010
Zhu, Z., Wang, G., Ma, K., Cui, S., & Wang, J. (2017) · Oncotarget · doi:10.18632/oncotarget.16411 · Cited by 75
Hayley, S. P., Du, L., Litteljohn, D., Palkovits, M., Faludi, G., Merali, Z., Poulter, M. O., & Anisman, H. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.05.052 · Cited by 78
Dentate gyrus volume and memory performance in major depressive disorder
Travis, S., Coupland, N. J., Silversone, P. H., Huang, Y., Fujiwara, E., Carter, R., Seres, P., & Malykhin, N. V. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.09.048 · Cited by 71
Drago, A., Crisafulli, C., Sidoti, A., & Serretti, A. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.05.009 · Cited by 82
“It must be anticipated that a limit of such perspective is that it does not include the other hypotheses that may explain MDD as for example neuroplasticity, inflammation, epigenetics and the monoaminergic theory (aan het Rot et al., 2009; Pittenger and Duman, 2008; Tanti and Belzung, 2010).”
BackgroundGuidotti, G., Calabrese, F., Auletta, F., Olivier, J., Racagni, G., Homberg, J. R., & Riva, M. A. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.252 · Cited by 82
“Neuropsychopharmacology Castren, 2005; Krishnan and Nestler, 2008; Martinowich et al, 2007; Pittenger and Duman, 2008).”
BackgroundThe habenula as a critical node in chronic stress-related anxiety
Jacinto, L., Mata, R., Novais, A., Marques, F., & Sousa, N. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.12.003 · Cited by 75
Exposure to Stressors Facilitates Long-Term Synaptic Potentiation in the Lateral Habenula
Park, H., Rhee, J., Park, K., Han, J.-S., Malinow, R., & Chung, C. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2281-16.2017 · Cited by 70
“Stress exposure activates LHb neurons with limited specificity A growing body of literature indicates that stressful experiences may alter synaptic efficacy or synaptic plasticity in many brain areas that are reportedly involved in stress regulation or reward processing (Pittenger and Duman, 2008).”
BackgroundThomson, E. M., Filiatreault, A., & Guénette, J. (2019) · Environmental Research · doi:10.1016/j.envres.2019.108717 · Cited by 76
An, L., Zhang, Y., Yu, N.-J., Liu, X., Zhao, N., Yuan, L., Chen, H., & Li, Y. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.05.005 · Cited by 77
Imipramine Induces Brain-Derived Neurotrophic Factor mRNA Expression in Cultured Astrocytes
Takano, K., Yamasaki, H., Kawabe, K., Moriyama, M., & Nakamura, Y. (2012) · Journal of Pharmacological Sciences · doi:10.1254/jphs.12039fp · Cited by 70
Is There Anything Really Novel on the Antidepressant Horizon?
Murrough, J. W., & Charney, D. S. (2012) · Current Psychiatry Reports · doi:10.1007/s11920-012-0321-8 · Cited by 69
Longitudinal Changes in Depressive Circuitry in Response to Neuromodulation Therapy
Pathak, Y., Salami, O., Baillet, S., Li, Z., & Butson, C. R. (2016) · Frontiers in Neural Circuits · doi:10.3389/fncir.2016.00050 · Cited by 70
“…Harvard Medical School, USA Alik Sunil Widge, Massachusetts General Hospital, USA *Correspondence: Christopher R. Butson butson@sci.utah.edu Received: 16 July 2015 Accepted: 29 June 2016 Published: 29 July 2016 Citation: Pathak Y, Salami O, Baillet S, Li Z and Butson CR (2016) Longitudinal…”
BackgroundInfluentialProwse, N. A., & Hayley, S. P. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.09.018 · Cited by 78
“The role of BDNF in stressor related disorders has been a subject of intense research for decades (Björkholm and Monteggia, 2016; Duncan et al., 2013; Green et al., 2013; Jin et al., 2019; Kerman, 2012; Polyakova et al., 2015).”
BackgroundGe, R., Humaira, A., Gregory, E., Alamian, G., MacMillan, E. L., Barlow, L. R., Todd, R. M., Nestor, S. M., Frangou, S., & Vila‐Rodriguez, F. (2022) · American Journal of Psychiatry · doi:10.1176/appi.ajp.21050541 · Cited by 79
Han, X., Shao, W., Liu, Z., Fan, S., Yu, J. H., Chen, J., Qiao, R., Zhou, J., & Xie, P. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.04.006 · Cited by 78
Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease
Aboukhatwa, M., Dosanjh, L., & Luo, Y. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-10 · Cited by 69
“ferentiation of new neurons to functional ones [80].”
BackgroundMusazzi, L., Cattaneo, A., Tardito, D., Barbon, A., Gennarelli, M., Barlati, S., Racagni, G., & Popoli, M. (2009) · BMC Neuroscience · doi:10.1186/1471-2202-10-48 · Cited by 67
“In this framework BDNF has lately become, together with the activation of cAMP-response element binding protein (CREB), a sort of readout system in the study of antidepressant mechanisms [4,5,7,8,1014].”
BackgroundNeuroscience and the future for mental health?
Rose, N. (2016) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796015000621 · Cited by 61
“Or perhaps via a better understanding of neuro-plasticity in relation to different kinds of environmental inputs (Pittenger & Duman, 2008; Davidson & McEwen, 2012).”
Psychedelic therapy's transdiagnostic effects: A research domain criteria (RDoC) perspective
Kelly, J. R., Gillan, C. M., Prenderville, J., Kelly, C., Harkin, A., Clarke, G., & O'Keane, V. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.800072 · Cited by 69
“The classical psychedelics may share glutamatergic activitydependent neuroplastic effects with ketamine (175) and on a longer timescale, with some types of conventional antidepressants (176).”
BackgroundCortisol reduces cell proliferation in the telencephalon of rainbow trout (Oncorhynchus mykiss)
Sørensen, C., Bohlin, L. C., Øverli, Ø., & Nilsson, G. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2010.12.023 · Cited by 69
“[17–20]).”
Fink, G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802175-0.00001-2 · Cited by 73
Leptin-Induced Spine Formation Requires TrpC Channels and the CaM Kinase Cascade in the Hippocampus
Dhar, M., Wayman, G. A., Zhu, M., Lambert, T. J., Davare, M. A., & Appleyard, S. M. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.2868-13.2014 · Cited by 67
“…and that changes in spine number are associated with neurological disorders, with too few spines associated with learning and memory defects and depression, and too many spines with schizophrenia and autism (Irwin et al., 2000; Pittenger and Duman, 2008; Hajszan et al., 2009; Kasai et al., 2010).”
BackgroundSimon, A. F., Daniels, R. W., Romero‐Calderón, R., Grygoruk, A., Chang, H.-Y., Najibi, R., Shamouelian, D., Salazar, E., Solomon, M., Ackerson, L. C., et al. (2009) · Genetics · doi:10.1534/genetics.108.094110 · Cited by 74
Workman, J. L., Brummelte, S., & Galea, L. A. M. (2013) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2012.02380.x · Cited by 66
Grabe, H. J., Wittfeld, K., Van der Auwera, S., Janowitz, D., Hegenscheid, K., Habes, M., Homuth, G., Barnow, S., John, U., Nauck, M., et al. (2016) · Human Brain Mapping · doi:10.1002/hbm.23123 · Cited by 67
“An exaggerated cortisol response may then impair neuroplasticity [Pittenger and Duman, 2008] and trigger structural brain changes, which have been shown in animal models [Conrad et al., 1999; Vyas et al., 2002, 2006].”
BackgroundWang, H., Huang, B., Wang, W., Li, J., Chen, Y., Flynn, T., Zhao, M., Zhou, Z., Lin, X., Zhang, Y., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.09.049 · Cited by 72
“Stress is genrally considered the initial cause of the onset of, and a major ontributor to, depression [8,9].”
BackgroundBortolotto, V., Cuccurazzu, B., Canonico, P. L., & Grilli, M. (2014) · BioMed Research International · doi:10.1155/2014/612798 · Cited by 72
“Characteristics of aNSC are longterm self-renewal capacity and multipotentiality as they differentiate into multiple cell phenotypes, including neurons.”
BackgroundSah, A., Schmuckermair, C., Sartori, S. B., Gaburro, S., Kandasamy, M., Irschick, R., Klimaschewski, L., Landgraf, R., Aigner, L., & Singewald, N. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.94 · Cited by 67
Effect of meditation on neurophysiological changes in stress mediated depression
Kasala, E. R., Bodduluru, L. N., Maneti, Y., & Thipparaboina, R. (2013) · Complementary Therapies in Clinical Practice · doi:10.1016/j.ctcp.2013.10.001 · Cited by 74
Roles of Hippocampal Somatostatin Receptor Subtypes in Stress Response and Emotionality
Prévot, T. D., Gastambide, F., Viollet, C., Henkous, N., Martel, G., Epelbaum, J., Béracochéa, D., & Guillou, J. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.281 · Cited by 72
“…et al, 2012) or acute therapies with high-dose of corticoids (Brown, 2009) negatively impact hippocampal neuroplasticity, neurogenesis, and neuronal or glial survival in relationship with depression (Banasr and Duman, 2007; Banasr et al, 2011; Czeh and Lucassen, 2007; Pittenger and Duman, 2008).”
BackgroundCRH Signaling: Molecular Specificity for Drug Targeting in the CNS
Refojo, D., & Holsboer, F. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04983.x · Cited by 65
Arcego, D. M., Toniazzo, A. P., Krolow, R., Lampert, C., Berlitz, C., dos Santos Garcia, E., do Couto Nicola, F., Hoppe, J. B., Gaelzer, M. M., Klein, C. P., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0538-y · Cited by 66
Stress Controversies: Post-Traumatic Stress Disorder, Hippocampal Volume, Gastroduodenal Ulceration*
Fink, G. (2011) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2010.02089.x · Cited by 63
Calabrese, F., Molteni, R., Cattaneo, A., Macchi, F., Racagni, G., Gennarelli, M., Ellenbroek, B. A., & Riva, M. A. (2010) · Molecular Pharmacology · doi:10.1124/mol.109.063081 · Cited by 70
“…neuronal plasticity, driven by reduced expression and function of key mediators, such as the neurotrophin brain-derived neurotrophic factor (BDNF), which are important for cellular resilience (Tsankova et al., 2006; McClung and Nestler, 2008; Pittenger and Duman, 2008; Calabrese et al., 2009).”
BackgroundPlayer, M. J., Taylor, J. L., Weickert, C. S., Alonzo, A., Sachdev, P. S., Martin, D. M., Mitchell, P. B., & Loo, C. K. A. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.05.063 · Cited by 72
“The process of LTP relies on activation of NMDA receptors to increase postsynaptic calcium levels (Sweatt, 2008) and induce activitydependent cellular mechanisms that increase synaptic efficacy (Pittenger and Duman, 2008).”
BackgroundChronic glucocorticoid exposure activates BK-NLRP1 signal involving in hippocampal neuron damage
Zhang, B., Zhang, Y., Wu, W., Xu, T., Yin, Y., Zhang, J., Huang, D., & Li, W. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0911-9 · Cited by 66
“Chronic stress has been reported to be associated with many neurodegenerative diseases, such as depression, AD, and PD [2, 4, 49].”
BackgroundTsai, S., Wu, H., Chen, P., Chen, Y., Yu, M., Wang, T.-F., Wu, S.-Y., Tzeng, S., & Kuo, Y. (2018) · Brain Research · doi:10.1016/j.brainres.2018.07.017 · Cited by 69
Factors promoting vulnerability to dysregulated stress reactivity and stress‐related disease
Russell, A. L., Tasker, J. G., Lucion, A. B., Fiedler, J., Munhoz, C. D., Wu, T. J., & Deak, T. (2018) · Journal of Neuroendocrinology · doi:10.1111/jne.12641 · Cited by 59
Contraception counseling for women with premenstrual dysphoric disorder (PMDD): current perspectives
Rapkin, A. J., Korotkaya, Y., & Taylor, K. C. (2019) · Open Access Journal of Contraception · doi:10.2147/oajc.s183193 · Cited by 74
“44 SSRIs can also alter Allo levels, which may contribute to their effectiveness for the treatment of PMDD and MDD.55,45,46”
BackgroundGuerrera, C. S., Furneri, G., Grasso, M., Caruso, G., Castellano, S., Drago, F., Di Nuovo, S., & Caraci, F. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.00857 · Cited by 58
“, 2018b), as a risk factor for the development of MDD (Pittenger and Duman, 2008; Caraci et al., 2010).”
BackgroundBrain-immune crosstalk in the treatment of major depressive disorder
Branchi, I., Poggini, S., Capuron, L., Benedetti, F., Poletti, S., Tamouza, R., Drexhage, H. A., Penninx, B. W. J. H., & Pariante, C. M. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.11.016 · Cited by 64
Astroglial Control of the Antidepressant-Like Effects of Prefrontal Cortex Deep Brain Stimulation
Etiévant, A., Oosterhof, C., Bétry, C., Abrial, E., Novo-Perez, M., Rovera, R., Scarna, H., Devader, C., Mazella, J., Wegener, G., et al. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.06.023 · Cited by 65
“regulation of synaptic connectivity related to their therapeutic efficacy (Berton and Nestler, 2006; Pittenger and Duman, 2008).”
BackgroundMechanisms of brain glucocorticoid resistance in stress-induced psychopathologies
Merkulov, V. M., Merkulova, T. I., & Bondar, N. P. (2017) · Biochemistry (Moscow) · doi:10.1134/s0006297917030142 · Cited by 65
“Chronic stress contributes significantly to the development of various psychopathologies, including major depressive disorder (MDD) and bipolar disorder [1, 2].”
BackgroundMertens, L. J., & Preller, K. H. (2021) · Pharmacopsychiatry · doi:10.1055/a-1341-1907 · Cited by 65
“Preclinical and clinical research suggests synaptic loss in cortical and limbic areas, decreased neurogenesis, cortical (especially in the prefrontal cortex) and subcortical (hippocampus and other limbic structures) atrophy as well as depletion of brain derived neurotrophic factor (BDNF) are associated with depression…”
BackgroundGlutamatergic System in Depression and Its Role in Neuromodulatory Techniques Optimization
Khoodoruth, M. A. S., Estudillo‐Guerra, M. A., Pacheco‐Barrios, K., Nyundo, A., Chapa-Koloffon, G., & Ouanes, S. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.886918 · Cited by 73
Effects of chronic and acute stress on rat behaviour in the forced-swim test
Suvrathan, A., Tomar, A., & Chattarji, S. (2010) · Stress · doi:10.3109/10253890.2010.489978 · Cited by 75
Abercrombie, H. C., Jahn, A. L., Davidson, R. J., Kern, S., Kirschbaum, C., & Halverson, J. L. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.10.005 · Cited by 68
“GCs have potent effects on many aspects of hippocampal neuroplasticity, including effects on neurogenesis, synaptic plasticity, dendritic growth, and neurotrophic factors (Pittenger and Duman, 2008).”
InfluentialHippocampal Neurogenesis, Cognitive Deficits and Affective Disorder in Huntington's Disease
Ransome, M. I., Renoir, T., & Hannan, A. J. (2012) · Neural Plasticity · doi:10.1155/2012/874387 · Cited by 64
“Beyond cognition, however, impaired hippocampal neuronal plasticity is thought to be a significant neural substrate underlying the development of depressive behavior [9, 10].”
BackgroundUlloa, J. L., Castañeda, P., Berríos, C., Díaz‐Véliz, G., Mora, S., Bravo, J. A., Araneda, K., Menares, C., Morales, P., & Fiedler, J. L. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.08.001 · Cited by 68
“Chronic or severe stressors, as well as high levels of corticoids, are associated with a decline in hippocampal-dependentmemory (Brown et al., 2005; Fiedler et al., 2007; Lucassen et al., 2001; Magarinos et al., 1996; Pittenger and Duman, 2008).”
BackgroundO’Leary, O. F., O’Connor, R. M., & Cryan, J. F. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.015 · Cited by 75
“However, it is important to note that both lithium and antidepressant drugs can have pro-cognitive effects under conditions that challenge cognitive function including CNS trauma, neurodegeneration or stress (Fiorentini et al., 2010; Pittenger and Duman, 2008; Tsaltas et al., 2009).”
Fear Extinction as a Model for Synaptic Plasticity in Major Depressive Disorder
Kuhn, M., Höger, N., Feige, B., Blechert, J., Normann, C., & Nissen, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115280 · Cited by 66
“On the molecular level, these changes in the two systems of emotion processing in MDD might be explained by the contrasting effects of chronic stress as a key mediator of MDD [27].”
BackgroundNeural Mechanisms of Exercise: Anti-Depression, Neurogenesis, and Serotonin Signaling
Yuan, T.-F., Paes, F., Arias-Carrión, O., Ferreira Rocha, N., de Sá Filho, A., & Machado, S. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527315666151111124402 · Cited by 65
“In the last few years people discovered that antidepressant drugs can enhance dendritic complexity [53, 54] and increase the number of new neurons born in the hippocampus of adult animals in a non-acute, chronic time course [55].”
BackgroundSelectively Bred Rodents as Models of Depression and Anxiety
Wegener, G., Mathé, A. A., & Neumann, I. D. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2011_192 · Cited by 73
“Opposing effects of prenatal stress were also found with respect to hippocampal neurogenesis, which has been shown to be stress-sensitive and implicated in depression (Pittenger and Duman 2008).”
BackgroundThe Neurobiology of Motivational Deficits in Depression—An Update on Candidate Pathomechanisms
Treadway, M. T. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_400 · Cited by 73
“2006) and reduced expression of proteins involved in neurogenesis and synaptic plasticity (Kempermann and Kronenberg 2003; Dwivedi et al. 2005; Pittenger and Duman 2007) have been observed.”
BackgroundSawamoto, A., Okuyama, S., Yamamoto, K., Amakura, Y., Yoshimura, M., Nakajima, M., & Furukawa, Y. (2016) · Molecules · doi:10.3390/molecules21040541 · Cited by 68
“BDNF is the most abundant neurotrophic factor in the brain and plays an important role not only in neural development, survival, and function, but also in neurogenesis and neuroplasticity, both of which are important targets for depressive disorder treatments [30].”
BackgroundLi, X., Wu, T., Yu, Z., Li, T., Zhang, J., Zhang, Z., Cai, M., Zhang, W., Xiang, J. Y., & Cai, D. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.01.137 · Cited by 66
Khan, A. R., Geiger, L., Wiborg, O., & Czéh, B. (2020) · Cells · doi:10.3390/cells9041026 · Cited by 71
“Fortunately, it is now clear that animal models based on chronic stress protocols recapitulate many of the structural alterations that have been demonstrated in the brains of depressed patients, therefore such models are valuable tools to investigate the pathophysiology of the disease [12,13].”
BackgroundParul, P., Mishra, A., Singh, S., Singh, S., Tiwari, V., Chaturvedi, S., Wahajuddin, M., Palit, G., & Shukla, S. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.04.017 · Cited by 69
TRP Modulation by Natural Compounds
Meotti, F. C., de Andrade, E. L., & Calixto, J. Β. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-05161-1_19 · Cited by 71
Epigenetic mechanisms in mood disorders: Targeting neuroplasticity
Fass, D. M., Schroeder, F. A., Perlis, R. H., & Haggarty, S. J. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2013.01.041 · Cited by 62
“Despite intensive basic research and clinical studies, our understanding of the etiology and pathophysiology of mood disorders is severely limited (Manji and Duman, 2001, Quiroz and Manji, 2002, Krishnan and Nestler, 2008, Pittenger and Duman, 2008).”
BackgroundSeo, M. K., Lee, C. H., Cho, H. Y., Lee, J. G., Lee, B. J., Kim, J. E., Seol, W., Kim, Y. H., & Park, S. W. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.11.019 · Cited by 68
Rugulies, R., Ando, E., Ayuso‐Mateos, J. L., Bonafede, M., Cabello, M., Tecco, C. D., Dragano, N., Durand-Moreau, Q. V., Eguchi, H., Gao, J., et al. (2019) · Environment International · doi:10.1016/j.envint.2018.11.011 · Cited by 69
“(b) exhaustion, (c) emotional distress, (d) health-related behaviors, such as lack of physical activity, high alcohol consumption and reduced sleeping hours, and (e) psycho-physiological changes, such as activation of the hypothalamic-pituitary-adrenal (HPA) axis, inflammation processes, circadian disruptions, and sle…”
BackgroundMarsden, W. N. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.06.021 · Cited by 73
“duced in the brain in depression [27], and consistently reduced serum BDNF levels have been reported in stress-related mood dis-”
BackgroundResultInfluentialNitric oxide signalling and antidepressant action revisited
Joca, S. R. L., Sartim, A. G., Roncalho, A. L., Diniz, C. F. A., & Wegener, G. (2019) · Cell and Tissue Research · doi:10.1007/s00441-018-02987-4 · Cited by 63
Hippocampal subfield analysis in medication-naïve female patients with major depressive disorder
Han, K.-M., Won, E., Sim, Y., & Tae, W.-S. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.01.019 · Cited by 63
The involvement of ERK/CREB/Bcl-2 in depression-like behavior in prenatally stressed offspring rats
Guan, L., Jia, N., Zhao, X., Zhang, X., Tang, G., Yang, L., Sun, H., Wang, D., Su, Q., Song, Q., et al. (2013) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2013.08.003 · Cited by 65
Soares, L. M., Schiavon, A. P., Milani, H., & de Oliveira, R. M. W. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.04.010 · Cited by 66
“Elevated glucocorticoid levels have been related to decreased hippocampal neurogenesis [61] and with the development of anxiety-like behaviors [62,63].”
BackgroundHan, L., Zhang, L., Li, L., Sun, Y., Wang, Y., Chen, L., Guo, Y., Zhang, Y., Zhang, Q.-J., & Liu, J. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.01.024 · Cited by 66
“Key roles for monoamines in depression have been established for decades since antidepressant drugs can increase levels of DA, 5HT and NA in the limbic and limbic-related brain regions (Berton and Nestler, 2006; Pittenger and Duman, 2008; Smolders et al., 2008).”
BackgroundBrain, networks, depression, and more
Leistedt, S., & Linkowski, P. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.10.011 · Cited by 70
“Chronically administered antidepressants have also been shown to upregulate the transcription factor CREB (cyclic AMP response element-binding protein), which is downstream of several serotonin and other stimulatory G-protein-coupled receptors in the hippocampus; this effect has been validated in post mortem human tis…”
BackgroundZeng, B., Li, Y., Niu, B., Wang, X., Cheng, Y., Zhou, Z., You, T., Liu, Y., Wang, H., & Xu, J. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0779-7 · Cited by 63
Norbury, R., Selvaraj, S., Taylor, M. J., Harmer, C., & Cowen, P. J. (2010) · Psychological Medicine · doi:10.1017/s0033291709990596 · Cited by 62
“Although these participants had been drug free for long periods of time (see Method) it is possible that long-lasting neuroplastic effects of antidepressant medication could have influenced our imaging findings (Pittenger & Duman, 2008).”
BackgroundGut microbiota and neuropsychiatric disorders: Implications for neuroendocrine-immune regulation
Ge, T., Yao, X., Zhao, H., Yang, W., Zou, X., Peng, F., Li, B., & Cui, R. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105909 · Cited by 65
Chen, L., Klooster, D., Tik, M., Thomas, E. H. X., Downar, J. H., Fitzgerald, P. B., Williams, N., & Baeken, C. (2023) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000364 · Cited by 67
“Intersession Interval (ISI) and the Implicated Cellular and Physiological Mechanisms Depression of mood is associated with brain changes such as the loss of dendritic spines, synapses and glial cells, and dendritic atrophy in the prefrontal cortex and hippocampus,(123) while successful treatment with antidepressant me…”
BackgroundHorst, G. J. T. (2010) · Vitamins and hormones · doi:10.1016/s0083-6729(10)82017-5 · Cited by 70
“Estrogen, Stress, and Neuroplasticity Estrogens have an effect on neuronal plasticity and this is deemed critical to a healthy brain and coping with chronic stress (Pittenger and Duman, 2008).”
BackgroundCrupi, R., Mazzon, E., Marino, A., Spada, G. L., Bramanti, P., Battaglia, F., Cuzzocrea, S., & Spina, E. (2011) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-11-7 · Cited by 67
“There is growing evidence that many of these chronic stress-induced structural changes in the hippocampus can be reversed by antidepressant treatment [27-29].”
Chronic pain and adult hippocampal neurogenesis: translational implications from preclinical studies
Grilli, M. (2017) · Journal of Pain Research · doi:10.2147/jpr.s146399 · Cited by 65
“12,26 Although still debated, it has been proposed that ahNG may be required for some behavioral effects of antidepressants in preclinical models and may potentially contribute to the antidepressant activity of these drugs also in the clinical setting.”
Camargo, A., Dalmagro, A. P., Rikel, L., da Silva, E. B., da Silva, K. A. B. S., & Zeni, A. L. B. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.07.002 · Cited by 65
Ketamine regulates the presynaptic release machinery in the hippocampus
Müller, H. K., Wegener, G., Liebenberg, N., Zarate, C. A., Popoli, M., & Elfving, B. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.03.008 · Cited by 61
“These mechanisms are also involved in the therapeutic effect after chronic treatment with monoamine-based antidepressants (Pittenger and Duman, 2008) and thus, could suggest a final common pathway for the action of ketamine and structurally unrelated antidepressants.”
BackgroundTsou, J. Y. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108588485 · Cited by 77
“Similar mechanisms (e.g., disrupted neuoroplasticity, functional abnormalities in the dorsolateral PFC) are implicated in the cognitive impairments observed in schizophrenia and depressions (Lewis & González-Burgos, 2008; Pittenger & Duman, 2008).”
BackgroundExtracellular Vesicles and the Stress System
Makrygianni, E. A., & Chrousos, G. P. (2022) · Neuroendocrinology · doi:10.1159/000527182 · Cited by 61
Zhou, H., Lu, S.-Z., Yu, Z.-S., Zhang, J., & Mei, Z. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155251 · Cited by 63
Bambico, F. R., & Belzung, C. (2012) · Current topics in behavioral neurosciences · doi:10.1007/7854_2012_234 · Cited by 68
“ADT treatment (Karege et al. 2005; Pittenger and Duman, 2008), suggesting a”
Failla, M. D., Juengst, S. B., Arenth, P. M., & Wagner, A. K. (2015) · Neurorehabilitation and neural repair · doi:10.1177/1545968315600525 · Cited by 68
“Serum BDNF is likely reflective of BDNF expression in the hippocampus, where tissue BDNF levels are decreased in correlation with stress and depression.(60) Hippocampal BDNF signaling is also implicated in mechanisms of antidepressant treatment.”
Caudal, D., Godsil, B. P., Mailliet, F., Bergerot, D., & Jay, T. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015282 · Cited by 70
Papke, R. L., Trocmé, C., Guendisch, D., Rubaiy, S. A. A. A., & Bloom, S. A. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.177485 · Cited by 62
“In addition, depression is strongly associated with stress and stressrelated increases in glucocorticoids (Pittenger and Duman, 2008), and chronic elevations in corticoids have been shown to reduce the expression and function of homomeric 7-type receptors in the brain (Bullock et al.”
BackgroundSchattauer, S. S., Bedini, A., Summers, F., Reilly-Treat, A., Andrews, M. M., Land, B. B., & Chavkin, C. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.009592 · Cited by 63
Adult neuroplasticity: A new “cure” for major depression?
Albert, P. R. (2019) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.190072 · Cited by 66
How Stress Shapes Neuroimmune Function: Implications for the Neurobiology of Psychiatric Disorders
Koo, J. W., & Wohleb, E. S. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.11.007 · Cited by 65
Scott, S. M., Wallander, J. L., & Cameron, L. D. (2015) · Clinical Child and Family Psychology Review · doi:10.1007/s10567-015-0188-4 · Cited by 62
“problems with neurogenesis are believed to be a key component of major depression (Duman 2004; Pittenger and Duman 2008; Santarelli et al. 2003).”
BackgroundNaumenko, V. S., Kondaurova, E. M., Базовкина, Д. В., Tsybko, A. S., Tikhonova, M. A., Kulikov, A. V., & Popova, N. K. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.04.031 · Cited by 59
Zeni, A. L. B., Zomkowski, A. D. E., Maraschin, M., Rodrigues, A. L. S., & Tasca, C. I. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.08.020 · Cited by 61
“Modulation of diverse protein kinases directly or indirectly converges to the activation of CREB, mainly through PKA, CaMKII and MAPK as well as PI3K and PKC activation (Mathew et al., 2008; Pittenger and Duman, 2008).”
Calabrese, F., Guidotti, G., Middelman, A., Racagni, G., Homberg, J. R., & Riva, M. A. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8449-z · Cited by 68
Workman, J. L., Manny, N., Walton, J. C., & Nelson, R. J. (2011) · Hormones and Behavior · doi:10.1016/j.yhbeh.2011.07.021 · Cited by 69
“Selective serotonin reuptake inhibitors (SSRIs) stimulate hippocampal regeneration through neurogenesis and synaptic growth (Bessa et al., 2009; Pittenger and Duman, 2008; Wang et al., 2008).”
Mugge, L., Mansour, T. R., Crippen, M., Alam, Y., & Schroeder, J. L. (2018) · Neurosurgical Review · doi:10.1007/s10143-018-1017-2 · Cited by 65
Pignatelli, M., Tejeda, H. A., Barker, D. J., Bontempi, L., Wu, J., Lopez, A., Ribeiro, S. P., Lucantonio, F., Parise, E. M., Torres‐Berrío, A., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0686-8 · Cited by 63
Trifu, S. C., Trifu, A. C., Aluaş, E., Tătaru, M. A., & Costea, R. V. (2020) · Romanian Journal of Morphology and Embryology · doi:10.47162/rjme.61.2.06 · Cited by 59
Bétry, C., Etiévant, A., Pehrson, A., Sánchez, C., & Haddjeri, N. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.12.002 · Cited by 59
“Tight link between hippocampal plasticity, depression andmemory has been suggested (Gomez-Galan et al., 2013; Pittenger and Duman, 2008).”
Corbett, A. M., McGowin, A. E., Sieber, S., Flannery, T., & Sibbitt, B. (2012) · Laboratory Animals · doi:10.1258/la.2012.012018 · Cited by 64
Inomata, T., Iwagami, M., Nakamura, M., Shiang, T., Fujimoto, K., Okumura, Y., Iwata, N., Fujio, K., Hiratsuka, Y., Hori, S., et al. (2020) · The Ocular Surface · doi:10.1016/j.jtos.2020.02.007 · Cited by 59
Naumenko, V. S., Kulikov, A. V., Kondaurova, E. M., Tsybko, A. S., Kulikova, E. A., Krasnov, I. B., Shenkman, E. A., Sychev, V. N., Bazhenova, E. Y., Sinyakova, N. A., et al. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.10.045 · Cited by 60
“The deficiency of the BDNF is considered to play an important role in the pathogenesis of depression and mood disorders (Pittenger and Duman, 2008; Schmidt et al., 2008; Carlino et al., 2013).”
Background
Metadata
- Authors
- Pittenger, C., & Duman, R. S.
- Affiliations
- Yale University (US)
- Corresponding author
- Duman, Ronald S
- Venue
- Neuropsychopharmacology
- Published
- 2007-09-12
- Volume
- 33
- Issue
- 1
- Pages
- 88-109
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W1978891587
- Cited by
- 1,795
- References
- 257
- Citations by year
- 2026: 48 · 2025: 77 · 2024: 83 · 2023: 73 · 2022: 98 · 2021: 137 · 2020: 107 · 2019: 95 · 2018: 97 · 2017: 105 · 2016: 97 · 2015: 99 · 2014: 112 · 2013: 108 · 2012: 147
- FWCI
- 6.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- chronic stress, depression, neuroplasticity, antidepressants, structural plasticity, adult neurogenesis, synaptic plasticity, dendritic spine morphology, mood disorders, animal models of stress, depression pathophysiology
- MeSH terms
- Animals, Depression, Humans, Learning Disabilities, Memory Disorders, Models, Neurological, Neuronal Plasticity, Neurons, Stress, Physiological, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.